Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples

被引:29
|
作者
Porcelli, Stefano [1 ]
Kasper, Siegfried [2 ]
Zohar, Joseph [3 ,4 ]
Souery, Daniel [5 ,6 ]
Montgomery, Stuart [7 ]
Ferentinos, Panagiotis [8 ]
Rujescu, Dan [9 ]
Mendlewicz, Julien [10 ]
Pich, Emilio Merlo [7 ,11 ]
Pollentier, Stephane [12 ]
Penninx, Brenda W. J. H. [13 ,14 ]
Serretti, Alessandro [1 ]
机构
[1] Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy
[2] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria
[3] Sheba Med Ctr, Dept Psychiat, Tel Hashomer, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[5] Univ Libre Bruxelles, Lab Psychol Med, Brussels, Belgium
[6] Ctr Europeen Psychol Med, Psy Pluriel, Brussels, Belgium
[7] Imperial Coll Sch Med, London, England
[8] Athens Univ, Dept Psychiat, Med Sch, Athens, Greece
[9] Martin Luther Univ Halle Wittenberg, Univ Clin Psychiat Psychotherapy & Psychosomat, Halle, Germany
[10] Univ Libre Bruxelles, Brussels, Belgium
[11] Takeda Pharmaceut Int, Neurosci Therapeut Area Unit, Zurich, Switzerland
[12] Boehringer Ingelhe Pharma GmbH & Co KG, CNS Dis Res, Biberach, Germany
[13] Vrije Univ, Amsterdam UMC, Dept Psychiat, Amsterdam Neurosci, Amsterdam, Netherlands
[14] Vrije Univ, Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands
关键词
Social dysfunction; Schizophrenia; Mood disorders; Socio-demographic factors; Lifestyle factors; TREATMENT ENHANCEMENT PROGRAM; QUALITY-OF-LIFE; BIPOLAR DISORDER; RESISTANT DEPRESSION; ANTIPSYCHOTIC TRIALS; NEGATIVE SYMPTOMS; ADJUSTMENT SCALE; NATIONAL-INSTITUTE; CIGARETTE-SMOKING; MAJOR DEPRESSION;
D O I
10.1016/j.pnpbp.2019.109835
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Social dysfunction is a common symptom of several neuropsychiatric disorders. However, only in the last few years research began to systematically investigate clinical aspects of this relevant outcome. Interestingly, its distribution and link with other clinical variables is still unclear. This study investigated social dysfunction in 4 different cohorts of patients affected by mood disorders and schizophrenia to evaluate 1) the degree of social dysfunction in these populations; 2) the associations among social dysfunction and socio-demographic and psychopathological features. Methods: Data from 4 independent studies (CATIE, GSRD ES1, ES2 and ES3, STAR"D, STEP-BD) were investigated. Behavioural and affective indicators of social dysfunction were derived and operationalized from scales or questionnaire items related to the interaction with relatives, friends and significant people in patients affected by schizophrenia (N = 765) and mood disorders (N = 2278 + 1954 + 1829). In particular the social dysfunction indicator was derived from Sheehan Disability Scale (SDS) for GSRD sample, from the Work and Social Adjustment Scale (WSAS) for STAR*D sample, from the Life-Range of Impaired Functioning Tool (LRIFT) for STEP-BD sample, and from the Quality of Life Scale (QOLS) for CATIE sample. The distribution of social dysfunction was described and association with socio-demographic and psychopathological characteristics were analysed. Results: Social dysfunction indicators showed a broad distribution in all samples investigated. Consistently across studies, social dysfunction was associated with higher psychopathological severity (all samples except CATIE) and suicide risk (GSRD ES1 and ES2, STAR"D, and STEP-BD) that explain up to 47% of the variance, but also to lower education level (GSRD ES2, STAR"D, CATIE, and STEP-BD), poorer professional/work status (GSRD ES2 and ES3, STAR"D, CATIE, and STEP-BD), marital status (STAR*D and CATIE), age (younger age in GSRD ES1 and STAR"D, older age in CATIE), higher BMI (GSRD ES2 and ES3, and STEP-BD), and smoking (GSRD ES2 and ES3). Conclusion: Our results demonstrated that a significant percentage of patients affected by both mood disorders and schizophrenia shows relevant social dysfunction. Social dysfunction is related, but not completely explained by psychopathological severity. In several patients, it tends to persist also during remission state. Socio-demographic and lifestyle factors were also found to play a role and should therefore be taken into consideration in further studies investigating social dysfunction.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Review of Major Social Determinants of Health in Schizophrenia-Spectrum Psychotic Disorders: I. Clinical Outcomes
    Jester, Dylan J.
    Thomas, Michael L.
    Sturm, Emily T.
    Harvey, Philip D.
    Keshavan, Matcheri
    Davis, Beshaun J.
    Saxena, Shekhar
    Tampi, Rajesh
    Leutwyler, Heather
    Compton, Michael T.
    Palmer, Barton W.
    Jeste, Dilip, V
    SCHIZOPHRENIA BULLETIN, 2023, 49 (04) : 837 - 850
  • [42] CLINICAL-CRITERIA OF THE SOCIAL DANGER OF PATIENTS SUFFERING FROM SCHIZOPHRENIA (SYNDROMES WITH PREVAILING DELUSIONAL AND HALLUCINATORY DISORDERS)
    SHUMAKOV, VM
    SOKOLOVA, ED
    SVIRINOVSKY, YE
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1981, 81 (08): : 1218 - 1223
  • [43] Understanding social and clinical associations with unemployment for people with schizophrenia and bipolar disorders: large-scale health records study
    Chilman, Natasha
    Laporte, Dionne
    Dorrington, Sarah
    Hatch, Stephani L.
    Morgan, Craig
    Okoroji, Celestin
    Stewart, Robert
    Das-Munshi, Jayati
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2024, 59 (10) : 1709 - 1719
  • [44] Clinical profiles of stigma experiences, self-esteem and social relationships among people with schizophrenia, depressive, and bipolar disorders
    Oliveira, Sandra E. H.
    Esteves, Francisco
    Carvalho, Helena
    PSYCHIATRY RESEARCH, 2015, 229 (1-2) : 167 - 173
  • [45] Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects
    Schnack, Hugo G.
    Nieuwenhuis, Mireille
    van Haren, Neeltje E. M.
    Abramovic, Lucija
    Scheewe, Thomas W.
    Brouwer, Rachel M.
    Pol, Hilleke E. Hulshoff
    Kahn, Rene S.
    NEUROIMAGE, 2014, 84 : 299 - 306
  • [46] GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and reelin proteins in cerebellum (vol 72, pg 109, 2004)
    Fatemi, SH
    Stary, JM
    Earle, JA
    Araghi-Niknam, A
    Egan, E
    SCHIZOPHRENIA RESEARCH, 2005, 74 (2-3) : 287 - 287
  • [47] The Social Appearance Anxiety Scale in Italian Adolescent Populations: Construct Validation and Group Discrimination in Community and Clinical Eating Disorders Samples
    Antonios Dakanalis
    Giuseppe Carrà
    Rachel Calogero
    M. Assunta Zanetti
    Chiara Volpato
    Giuseppe Riva
    Massimo Clerici
    Pietro Cipresso
    Child Psychiatry & Human Development, 2016, 47 : 133 - 150
  • [48] The Social Appearance Anxiety Scale in Italian Adolescent Populations: Construct Validation and Group Discrimination in Community and Clinical Eating Disorders Samples
    Dakanalis, Antonios
    Carra, Giuseppe
    Calogero, Rachel
    Zanetti, M. Assunta
    Volpato, Chiara
    Riva, Giuseppe
    Clerici, Massimo
    Cipresso, Pietro
    CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2016, 47 (01) : 133 - 150
  • [49] COGNITIVE AND CLINICAL DYSFUNCTION IN CHINESE ADULT, NONPSYCHOTIC RELATIVES OF SCHIZOPHRENIA PATIENTS PREDICTS DEFICITS IN A WIDE RANGE OF NEUROPSYCHOLOGICAL, SOCIAL AND CLINICAL FUNCTIONS: FINDINGS FROM THE CHANGSHA STUDY
    Stone, William S.
    Hsi, X.
    Tan, L.
    Zhu, S.
    Li, L.
    Tsuang, M. T.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 300 - 300
  • [50] GABAA receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress:: Possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders
    Matsumoto, Kinzo
    Puia, Giulia
    Dong, Erbo
    Pinna, Graziano
    STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 2007, 10 (01): : 3 - 12